Trans-Resveratrol and ε-viniferin decrease glucose absorption in porcine jejunum and ileum in vitro

Comparative Biochemistry and Physiology - A Molecular and Integrative Physiology

Volumn 165, Issue 3, 2013, Pages 313-318

  Guschlbauer, Maria ^a   Klinger, Stefanie ^a   Burmester, Marion ^a   Horn, Jana ^a   Kulling, Sabine E ^b   Breves, Gerhard ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b FEDERAL RESEARCH INSTITUTE OF NUTRITION AND FOOD   (Germany)

Author keywords

Ileum; Jejunum; SGLT1; Trans Resveratrol; Viniferin

Indexed keywords

GLUCOSE; POLYPHENOL DERIVATIVE; RESVERATROL; SODIUM; UNCLASSIFIED DRUG; VINIFERIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUCOSE ABSORPTION; GLUCOSE TRANSPORT; ILEUM; IN VITRO STUDY; INTESTINE ABSORPTION; INTESTINE BRUSH BORDER MEMBRANE; JEJUNUM; NONHUMAN;

EID: 84877113651     PISSN: 10956433     EISSN: 15314332     Source Type: Journal    
DOI: 10.1016/j.cbpa.2013.03.040     Document Type: Article

References (44)

1. Ader P., Block M., Pietzsch S., Wolffram S. Interaction of quercetin glucosides with the intestinal sodium/glucose co-transporter (SGLT-1). Cancer Lett. 2001, 162:175-180.
2. Bai Y., Mao Q.Q., Qin J., Zheng X.Y., Wang Y.B., Yang K., Shen H.F., Xie L.P. Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo. Cancer Sci. 2010, 101:488-493.
3. Breen D.M., Sanli T., Giacca A., Tsiani E. Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK. Biochem. Biophys. Res. Commun. 2008, 374:117-122.
4. Cermak R., Landgraf S., Wolffram S. Quercetin glucosides inhibit glucose uptake into brush-border-membrane vesicles of porcine jejunum. Br. J. Nutr. 2004, 91:849-855.
5. Chen C.J., Yu W., Fu Y.C., Wang X., Li J.L., Wang W. Resveratrol protects cardiomyocytes from hypoxia-induced apoptosis through the SIRT1-FoxO1 pathway. Biochem. Biophys. Res. Commun. 2009, 378:389-393.
6. Chen C.J., Yu W., Wang W. Red wine may be used in the therapy of myocarditis. J. Cell Biochem. 2010, 111:808-810.
7. Chen Z.H., Hurh Y.J., Na H.K., Kim J.H., Chun Y.J., Kim D.H., Kang K.S., Cho M.H., Surh Y.J. Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells. Carcinogenesis 2004, 25:2005-2013.
8. Clarke L.L., Argenzio R.A. NaCl transport across equine proximal colon and the effect of endogenous prostanoids. Am. J. Physiol. 1990, 259:G62-G69.
9. Deng J.Y., Hsieh P.S., Huang J.P., Lu L.S., Hung L.M. Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and -independent pathways. Diabetes 2008, 57:1814-1823.
10. Hain R., Bieseler B., Kindl H., Schroder G., Stocker R. Expression of a stilbene synthase gene in Nicotiana tabacum results in synthesis of the phytoalexin resveratrol. Plant Mol. Biol. 1990, 15:325-335.
11. Henry-Vitrac C., Desmouliere A., Girard D., Merillon J.M., Krisa S. Transport, deglycosylation, and metabolism of trans-piceid by small intestinal epithelial cells. Eur. J. Nutr. 2006, 45:376-382.
12. Henry C., Vitrac X., Decendit A., Ennamany R., Krisa S., Merillon J.M. Cellular uptake and efflux of trans-piceid and its aglycone trans-resveratrol on the apical membrane of human intestinal Caco-2 cells. J. Agric. Food Chem. 2005, 53:798-803.
13. Herrmann J., Schroder B., Klinger S., Thorenz A., Werner A.C., Abel H., Breves G. Segmental diversity of electrogenic glucose transport characteristics in the small intestines of weaned pigs. Comp. Biochem. Physiol. A 2012, 163:161-169.
14. Jang J.H., Surh Y.J. Protective effects of resveratrol on hydrogen peroxide-induced apoptosis in rat pheochromocytoma (PC12) cells. Mutat. Res. 2001, 496:181-190.
15. Kang L., Heng W., Yuan A., Baolin L., Fang H. Resveratrol modulates adipokine expression and improves insulin sensitivity in adipocytes: relative to inhibition of inflammatory responses. Biochimie 2010, 92:789-796.
16. Kellett G.L. The facilitated component of intestinal glucose absorption. J. Physiol. 2001, 531:585-595.
17. Kinne R.K., Castaneda F. SGLT inhibitors as new therapeutic tools in the treatment of diabetes. Handb. Exp. Pharmacol. 2011, 105-126.
18. Klinger S., Noci B., Muller K., Breves G. Intestinal glucose absorption in calves as affected by different carbohydrate sources. J. Anim. Physiol. Anim. Nutr. (Berl.) 2013, (in press).
19. Kottra G., Daniel H. Flavonoid glycosides are not transported by the human Na+/glucose transporter when expressed in Xenopus laevis oocytes, but effectively inhibit electrogenic glucose uptake. J. Pharmacol. Exp. Ther. 2007, 322:829-835.
20. Kwon O., Eck P., Chen S., Corpe C.P., Lee J.H., Kruhlak M., Levine M. Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. FASEB J. 2007, 21:366-377.
21. Landrault N., Larronde F., Delaunay J.C., Castagnino C., Vercauteren J., Merillon J.M., Gasc F., Cros G., Teissedre P.L. Levels of stilbene oligomers and astilbin in French varietal wines and in grapes during noble rot development. J. Agric. Food. Chem. 2002, 50:2046-2052.
22. Larsen M.O., Wilken M., Gotfredsen C.F., Carr R.D., Svendsen O., Rolin B. Milde streptozotocin diabetes in the Gottingen minipig. A novel model for moderate insulin deficiency and diabetes. Am. J. Physiol. Endocrinol. Metab. 2002, 282:E1342-E1351.
23. Mazauric J.P., Salmon J.M. Interactions between yeast lees and wine polyphenols during simulation of wine aging: I Analysis of remnant polyphenolic compounds in the resulting wines. J. Agric. Food Chem. 2005, 53:5647-5653.
24. Mircheff A.K., Wright E.M. Analytical isolation of plasma membranes of intestinal epithelial cells: identification of Na, K-ATPase rich membranes and the distribution of enzyme activities. J. Membr. Biol. 1976, 28:309-333.
25. Moran A.W., Al-Rammahi M.A., Arora D.K., Batchelor D.J., Coulter E.A., Ionescu C., Bravo D., Shirazi-Beechey S.P. Expression of Na+/glucose co-transporter 1 (SGLT1) in the intestine of piglets weaned to different concentrations of dietary carbohydrate. Br. J. Nutr. 2010, 104:647-655.
26. Ohmori Y. Über die Phosphomonoesterase. Enzymologia 1937, 4:217-231.
27. Patterson J.K., Lei X.G., Miller D.D. The pig as an experimental model for elucidating the mechanisms governing dietary influence on mineral absorption. Exp. Biol. Med. 2008, 233:651-664.
28. Pervaiz S. Resveratrol: from grapevines to mammalian biology. FASEB J. 2003, 17:1975-1985.
29. Raja M.M., Tyagi N.K., Kinne R.K. Phlorizin recognition in a C-terminal fragment of SGLT1 studied by tryptophan scanning and affinity labeling. J. Biol. Chem. 2003, 278:49154-49163.
30. Saiko P., Szakmary A., Jaeger W., Szekeres T. Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad?. Mutat. Res. 2008, 658:68-94.
31. Schroder B., Breves G. Mechanisms of phosphate uptake into brush-border membrane vesicles from goat jejunum. J. Comp. Physiol. B 1996, 166:230-240.
32. Schulze C., Kottra G., Daniel H. Inhibition of the sodium-coupled glucose transporter SGLT1 by plant extracts and metabolites derived from apple and grape vine. Genes Nutr. 2012, 6:S61.
33. Smith P.L., Blumberg J.B., Stoff J.S., Field M. Antisecretory effects of indomethacin on rabbit ileal mucosa in vitro. Gastroenterol. 1981, 80:356-365.
34. Soleas G.J., Diamandis E.P., Goldberg D.M. Resveratrol: a molecule whose time has come? And gone?. Clin. Biochem. 1997, 30:91-113.
35. Strauss A., Tiubre C., Chodnevskaja I., Thiede A., Timm S., Ulrichs K., Moskalenko V. Use of continuous glucose monitoring system in Goettingen minipigs, with a special focus on the evaluation of insulin-dependent diabetes. Transplant. Proc. 2008, 40:536-539.
36. Tyagi N.K., Kumar A., Goyal P., Pandey D., Siess W., Kinne R.K. D-Glucose-recognition and phlorizin-binding sites in human sodium/D-glucose cotransporter 1 (hSGLT1): a tryptophan scanning study. Biochemistry 2007, 46:13616-13628.
37. Ussing H.H. The active ion transport through the isolated frog skin in the light of tracer studies. Acta Physiol. Scand. 1949, 17:1-37.
38. Ussing H.H. Transport of ions across cellular membranes. Physiol. Rev. 1949, 29:127-155.
39. Vang O., Ahmad N., Baile C.A., Baur J.A., Brown K., Csiszar A., Das D.K., Delmas D., Gottfried C., Lin1 H.-Y., Ma Q.-Y., Mukhopadhyay P., Nalini N., Pezzuto J.M., Richard T., Shukla Y., Surh Y.-J., Szekeres T., Szkudelski T., Walle T., Wu J.M. What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS ONE 2011, 6:1-11.
40. Vick H., Diedrich D.F., Baumann K. Reevaluation of renal tubular glucose transport inhibition by phlorizin analogs. Am. J. Physiol. 1973, 224:552-557.
41. Vitrac X., Bornet A., Vanderlinde R., Valls J., Richard T., Delaunay J.-C., Merillon J.-M., Teissedre P.-L. Determination of stilbenes (δ-viniferin, trans-astringin, trans-piceid, cis- and trans-resveratrol, ε-viniferin) in Brazilian wines. J. Agric. Food. Chem. 2005, 53:5664-5669.
42. von Heimendahl E., Breves G., Abel H.J. Fiber-related digestive processes in three different breeds of pigs. J. Anim. Sci. 2009, 88:972-981.
43. Yi S.M., Zhu J.L., Fu L.L., Li J.R. Tea polyphenols inhibit Pseudomonas aeruginosa through damage to the cell membrane. Int. J. Food Microbiol. 2010, 144:111-117.
44. Zghonda N., Yoshida S., Araki M., Kusunoki M., Mliki A., Ghorbel A., Miyazaki H. Greater effectiveness of epsilon-viniferin in red wine than its monomer resveratrol for inhibiting vascular smooth muscle cell proliferation and migration. Biosci. Biotechnol. Biochem. 2011, 75:1259-1267.